<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">BMC Infect. Dis</journal-id><journal-title-group><journal-title>BMC Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">1471-2334</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5496404</article-id><article-id pub-id-type="publisher-id">2570</article-id><article-id pub-id-type="doi">10.1186/s12879-017-2570-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Dissemination of Carbapenem-resistant <italic>Klebsiella pneumoniae</italic> clinical isolates with various combinations of Carbapenemases (KPC-2, NDM-1, NDM-4, and OXA-48) and 16S rRNA Methylases (RmtB and RmtC) in Vietnam</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Tada</surname><given-names>Tatsuya</given-names></name><address><email>ttada@ri.ncgm.go.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Tsuchiya</surname><given-names>Mitsuhiro</given-names></name><address><email>mtsuchiya@hosp.ncgm.go.jp</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Shimada</surname><given-names>Kayo</given-names></name><address><email>kshima@ri.ncgm.go.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Nga</surname><given-names>Tran Thi Thanh</given-names></name><address><email>ngatrancrh@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Thu</surname><given-names>Le Thi Anh</given-names></name><address><email>letathu@yahoo.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Phu</surname><given-names>Truong Thien</given-names></name><address><email>truongthienphu78@yahoo.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Ohmagari</surname><given-names>Norio</given-names></name><address><email>nohmagari@hosp.ncgm.go.jp</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kirikae</surname><given-names>Teruo</given-names></name><address><phone>(81) 3 3202 7181</phone><email>tkirikae@ri.ncgm.go.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0489 0290</institution-id><institution-id institution-id-type="GRID">grid.45203.30</institution-id><institution>Department of Infectious Diseases, Research Institute, </institution><institution>National Center for Global Health and Medicine, </institution></institution-wrap>1-21-1 Toyama, Shinjuku, Tokyo, 162-8655 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0489 0290</institution-id><institution-id institution-id-type="GRID">grid.45203.30</institution-id><institution>Disease Control and Prevention Center, Division of Infectious Diseases, </institution><institution>National Center for Global Health and Medicine, </institution></institution-wrap>Shinjuku, Tokyo, 162-8655 Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0620 1102</institution-id><institution-id institution-id-type="GRID">grid.414275.1</institution-id><institution/><institution>Cho Ray Hospital, </institution></institution-wrap>Ho Chi Minh, Vietnam </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1762 2738</institution-id><institution-id institution-id-type="GRID">grid.258269.2</institution-id><institution>Department of Microbiology, </institution><institution>Juntendo University School of Medicine, </institution></institution-wrap>Tokyo, 113-8421 Japan </aff></contrib-group><pub-date pub-type="epub"><day>4</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>4</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>17</volume><elocation-id>467</elocation-id><history><date date-type="received"><day>21</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>26</day><month>6</month><year>2017</year></date></history><permissions><copyright-statement>&#169; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Methods</title><p id="Par1">Twenty-seven clinical isolates of carbapenem-resistant <italic>Klebsiella pneumoniae</italic> with MICs &#8805;4&#160;mg/L for imipenem or meropenem were obtained from inpatients in a hospital in Vietnam. Antimicrobial susceptibility tests and whole genome sequencing were performed. Multilocus sequence typing and the presence of drug resistant genes were determined and a maximum-likelihood phylogenetic tree was constructed by SNP alignment of whole genome sequencing data.</p></sec><sec><title>Results</title><p id="Par2">All the isolates harbored one of genes encoding carbapenemases, including KPC-2, NDM-1, NDM-4 and OXA-48. Of the isolates, 13 were resistant to arbekacin with MICs &#8805;256&#160;mg/L and to amikacin with MICs &#8805;512&#160;mg/L. These isolates harbored a gene encoding a 16S rRNA methylase, either RmtB or RmtC. Eighteen and 4 isolates belonged to international clones, ST15 and ST16, respectively. None of the isolates had colistin-resistant factors.</p></sec><sec><title>Conclusion</title><p id="Par3">Carbapenem-resistant <italic>K. pneumoniae</italic> isolates belonged to international clones spread in a medical setting in Vietnam, and that these isolates harbored genes encoding various combinations of carbapenemases and 16S rRNA methylases. This is the first report of KPC-2, NDM-4 and OXA-48 producers in a medical setting in Vietnam.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Carbapenem-resistant <italic>Klebsiella pneumoniae</italic></kwd><kwd>Carbapenemase</kwd><kwd>Molecular epidemiology</kwd><kwd>MLST</kwd></kwd-group><funding-group><award-group><funding-source><institution>Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)</institution></funding-source></award-group><award-group><funding-source><institution>Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development</institution></funding-source></award-group><award-group><funding-source><institution>International Health Cooperation Research</institution></funding-source><award-id>27-A-1102</award-id><award-id>27-A-1102</award-id><principal-award-recipient><name><surname>Tada</surname><given-names>Tatsuya</given-names></name><name><surname>Kirikae</surname><given-names>Teruo</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution>JSPS KAKENHI </institution></funding-source><award-id>16K19133</award-id><principal-award-recipient><name><surname>Tada</surname><given-names>Tatsuya</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par8">Emergence of carbapenemase-producing <italic>Klebsiella pneumoniae</italic> isolates has become serious problems worldwide [<xref ref-type="bibr" rid="CR1">1</xref>]. These isolates produce several carbapenemases belonging to class A, B, and D, including KPCs, NDMs and OXA-48, respectively [<xref ref-type="bibr" rid="CR2">2</xref>]. KPC-1 was initially found in a carbapenem-resistant strain <italic>K. pneumoniae</italic> 1534, which was collected in a surveillance during 1996 to 1997 in the United States hospitals [<xref ref-type="bibr" rid="CR3">3</xref>]. NDM-1 was initially identified in <italic>K. pneumoniae</italic> and <italic>Escherichia coli</italic> in 2009 in Sweden [<xref ref-type="bibr" rid="CR4">4</xref>]. Since then, NDM-1-producing <italic>Enterobacteriaceae</italic> have been reported worldwide [<xref ref-type="bibr" rid="CR5">5</xref>]. OXA-48 was first identified in <italic>K. pneumoniae</italic> 11,978, which was isolated in 2001 in Turkey [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par9">
<italic>K. pneumoniae</italic> producing 16S rRNA methylase genes responsible for an extremely high level of resistance to various aminoglycosides have been increasingly reported [<xref ref-type="bibr" rid="CR7">7</xref>]. To date, 10 types of 16S rRNA methylases, including ArmA, RmtA, RmtB, RmtC, RmtD, RmtE, RmtF, RmtG, RmtH and NpmA, have been found in clinical isolates. Of them, RmtB spread widely among various bacterial species, including <italic>Acinetobacter baumannii</italic>, <italic>Enterobacteriaceae</italic> and <italic>Pseudomonas aeruginosa</italic>, and RmtC spread among <italic>Enterobacteriaceae</italic> [<xref ref-type="bibr" rid="CR7">7</xref>].</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Bacterial strains and antimicrobial susceptibility</title><p id="Par10">Twenty-seven <italic>K. pneumoniae</italic> isolates with minimum inhibitory concentrations (MICs) &#8805;4&#160;mg/L for imipenem or meropenem were obtained from 27 inpatients treated at a hospital, Vietnam, from from February 2014 to April 2015. Of them, 22 isolates were from respiratory tracts, 3 from pus samples, 1 from a bile sample, and 1 from a urine sample. The isolates were phenotypically identified and species identification was confirmed by 16S rRNA sequencing. MICs were determined using the microdilution method, according to the guidelines of the Clinical Laboratory Standards Institute (M100-S25). The colistin MICs were also determined by Etest in colistin-resistant isolates evaluated by broth microdilution method.</p></sec><sec id="Sec4"><title>Detection of antibiotic-resistance genes and their genetic environments</title><p id="Par11">The entire genome of each isolate was extracted by DNeasy Blood &amp; Tissue kit (QIAGEN, Tokyo, Japan) and sequenced by MiSeq (Illumina, San Diego, CA). Sequences of drug-resistance genes, including &#946;-lactamase encoding genes at the website (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pathogens/beta-lactamase-data-resources">https://www.ncbi.nlm.nih.gov/pathogens/beta-lactamase-data-resources/</ext-link>), aminoglycoside resistance genes (aminoglycoside-acetyltransferase, &#8722;adenylyltransferase and -phosphotransferase encoding genes), colistin resistance genes (<italic>mcr-1</italic>, <italic>mcr-2</italic> and <italic>mgrB</italic>), registered in GenBank (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore">http://www.ncbi.nlm.nih.gov/nuccore/</ext-link>) and quinolone resistance genes <italic>gyrA</italic> and <italic>parC</italic>, were determined using CLC genomics workbench version 9.0.1. Genetic environments surrounding <italic>bla</italic>
<sub>KPC-2</sub>, <italic>bla</italic>
<sub>NDMs</sub> and <italic>bla</italic>
<sub>OXA-48</sub> and the genes encoding the 16S rRNA methylases were determined.</p></sec><sec id="Sec5"><title>MLST and phylogenetic analysis</title><p id="Par12">Multilocus sequence types (MLSTs) were deduced as described in the protocols of the Institut Pasteur MLST (IP-MLST) (<ext-link ext-link-type="uri" xlink:href="http://bigsdb.pasteur.fr/klebsiella/klebsiella.html">http://bigsdb.pasteur.fr/klebsiella/klebsiella.html</ext-link>) databases. Clonal complexes (CC) were determined by eBURST version 3 (<ext-link ext-link-type="uri" xlink:href="http://eburst.mlst.net">http://eburst.mlst.net</ext-link>). Single nucleotide polymorphisms (SNPs) of the genome sequences of all carbapenem-resistant isolates tested were identified by comparisons with the sequence of NDM-1 producing ST15 <italic>K. pneumoniae</italic> PMK1, (Gen Bank accession no. CP008929), with all the reads of each isolate aligned against the PMK1 sequence using CLC Genomic Workbench version 9.0.1. SNP concatenated sequences were aligned using MAFFT (<ext-link ext-link-type="uri" xlink:href="http://www.mafft.cbrc.jp/alignment/server/">http:/mafft.cbrc.jp/alignment/server/</ext-link>). Phylogenetic trees were constructed from the SNP concatemers. Models and parameters used for the phylogenetic analyses were computed using j-Model Test-2.1.4. A maximum-likelihood phylogenetic tree was constructed from SNP alignment with PhyML 3.0.</p></sec><sec id="Sec6"><title>Pulsed-field gel electrophoresis and southern hybridization</title><p id="Par13">The plasmids in each ST strain were extracted and pulsed-field gel electrophoresis was performed as describing previously [<xref ref-type="bibr" rid="CR8">8</xref>]. Probes for <italic>bla</italic>
<sub>KPC-2</sub>, <italic>bla</italic>
<sub>NDMs</sub> and <italic>bla</italic>
<sub>OXA-48</sub> were amplified by PCR using the primer sets as follows; KPC-F-TCGCTAAACTCGAACAGG and KPC-R-TTACTGCCCGTTGACGCCCAATCC for <italic>bla</italic>
<sub>KPC-2</sub>, NDM-F- TTGGCCTTGCTGTCCTTG and NDM-R- ACACCAGTGACAATATCACCG for <italic>bla</italic>
<sub>NDMs</sub> and OXA-48-F-TGTTTTTGGTGGCATCGAT and OXA-48-R-GTAAMRATGCTTGGTTCGC for <italic>bla</italic>
<sub>OXA-48</sub>, respectively. Signal detection was carried out using DIG High Prime DNA Labeling and Detection Starter Kit II (Roche Applied Science, Indianapolis, IN).</p></sec><sec id="Sec7"><title>Nucleotide sequence accession numbers</title><p id="Par14">The whole genome sequences of all 27 isolates have been deposited at GenBank as accession numbers DRA005275.</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Antimicrobial susceptibility</title><p id="Par15">MICs of 27 carbapenem-resistant isolates were shown in Table <xref rid="Tab1" ref-type="table">1</xref>. All the isolates had MIC<sub>50</sub> 8&#160;mg/L and MIC<sub>90</sub> 64&#160;mg/L for imipenem, and MIC<sub>50</sub> 8&#160;mg/L and MIC<sub>90</sub> 128&#160;mg/L for meropenem. They were resistant to ampicillin with MICs &#8805;1024&#160;mg/L, to aztreonam with MIC<sub>50</sub> 512&#160;mg/L and MIC<sub>90</sub> 1024&#160;mg/L, to ceftazidime with MIC<sub>50</sub> 256&#160;mg/L and MIC<sub>90</sub>&#160;&gt;&#160;1024&#160;mg/L, and to ciprofloxacin with MIC<sub>50</sub> 256&#160;mg/L and MIC<sub>90</sub> 512&#160;mg/L. Of all the isolates, 19 isolates (70%) were resistant to amikacin with MIC<sub>50</sub> 1024&#160;mg/L and MIC<sub>90</sub>&#160;&gt;&#160;1024&#160;mg/L. They had MIC<sub>50</sub> 256&#160;mg/L and MIC<sub>90</sub>&#160;&gt;&#160;1024&#160;mg/L for arbekacin, MIC<sub>50</sub> 0.25&#160;mg/L and MIC<sub>90</sub> 32&#160;mg/L to colistin, and MIC<sub>50</sub> 2&#160;mg/L and MIC<sub>90</sub> 2&#160;mg/L to tigecycline. The colistin MICs of <italic>K. pneumoniae</italic> isolates were significantly higher by the microdilution method than by Etest. MICs of colistin using Etest were from 0.75 to 2&#160;mg/L (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of the characteristics of the 27&#160;<italic>Klebsiella pneumoniae</italic> strains, including antimicrobial resistance profiles, resistance genes and MLST</p></caption><table-wrap-foot><p>
<italic>MIC</italic>, minimum inhibitory concentration, <italic>ABK</italic> arbekacin, <italic>AMK</italic> amikacin, <italic>AMP</italic> ampicillin, <italic>AZT</italic> azidothymidine, <italic>CAZ</italic> ceftazidime, <italic>CIP</italic> ciprofloxacin, <italic>CST</italic> colistin, <italic>IPM</italic> imipenem, <italic>MEM</italic> meropenem, <italic>TGC</italic> tigecycline, <italic>ESBL</italic> extended-spectrum-lactamase, <italic>ND</italic> not determined</p><p>
<sup>a</sup>MICs for colistin using Etest are given in parentheses</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec10"><title>Drug resistant genes</title><p id="Par16">All isolates tested had a carbapenemase encoding gene, such as <italic>bla</italic>
<sub>KPC-2</sub>, <italic>bla</italic>
<sub>NDM-1</sub>, <italic>bla</italic>
<sub>NDM-4</sub> and <italic>bla</italic>
<sub>OXA-48</sub>; and the majority had a 16S rRNA methylase encoding gene, such as <italic>rmtB</italic> and <italic>rmtC</italic> (Table <xref rid="Tab1" ref-type="table">1</xref>). Of the all isolates, 19 had <italic>bla</italic>
<sub>OXA-48</sub>, 5 had <italic>bla</italic>
<sub>NDM-4</sub>, 2 had <italic>bla</italic>
<sub>NDM-1</sub>, and 1 had <italic>bla</italic>
<sub>KPC-2</sub>. Seventeen had <italic>rmtB</italic> and 2 had <italic>rmtC</italic>. These isolates also had (an) extended spectrum &#946;-lactamase encoding gene(s), including <italic>bla</italic>
<sub>CTX-M-14</sub>, <italic>bla</italic>
<sub>CTX-M-15</sub>, <italic>bla</italic>
<sub>CTX-M-27</sub>, <italic>bla</italic>
<sub>SHV-1</sub>, <italic>bla</italic>
<sub>SHV-11</sub>, <italic>bla</italic>
<sub>SHV-12</sub>, <italic>bla</italic>
<sub>SHV-28</sub>, <italic>bla</italic>
<sub>SHV-55</sub>, and/or <italic>bla</italic>
<sub>TEM-1</sub>; and aminoglycoside modification enzymes, including <italic>aac(6&#8242;)-Ib-cr</italic> and/or <italic>aadA1</italic> (Table <xref rid="Tab1" ref-type="table">1</xref>). All isolates had 2 or 3 point mutations in the quinolone-resistance-determining regions of <italic>gyrA</italic> and <italic>parC</italic> (Table <xref rid="Tab1" ref-type="table">1</xref>). None of the isolates harbor <italic>mcr-1</italic> or <italic>mcr-2</italic>, and our analysis did not reveal any isolates with disruption in the <italic>mrgB</italic> gene.</p></sec><sec id="Sec11"><title>Genetic environments surrounding genes encoding carbapenemases</title><p id="Par17">The genetic structure surrounding <italic>bla</italic>
<sub>KPC-2</sub>, <italic>bla</italic>
<sub>NDM-1</sub>, <italic>bla</italic>
<sub>NDM-4</sub> and <italic>bla</italic>
<sub>OXA-48</sub> were shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. The genomic structure surrounding <italic>bla</italic>
<sub>KPC-2</sub> was identical with that of <italic>Aeromonas hydrophila</italic> strain WCHAH01 plasmid pKPC2 (GenBank accession no. KR014106), which was isolated in China.<fig id="Fig1"><label>Fig. 1</label><caption><p>The structure of genetic environments surrounding <italic>bla</italic>
<sub>KPC-2</sub>, <italic>bla</italic>
<sub>NDM-1</sub>, <italic>bla</italic>
<sub>NDM-4</sub> and <italic>bla</italic>
<sub>OXA-48</sub>
</p></caption><graphic xlink:href="12879_2017_2570_Fig1_HTML" id="MO1"/></fig>
</p><p id="Par18">All isolates harboring <italic>bla</italic>
<sub>NDM-1</sub> tested had the same genetic structure surrounding <italic>bla</italic>
<sub>NDM-1</sub> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>), which was identical with that of plasmid pRIH26 in NDM-1 producing <italic>K. pneumoniae</italic> isolated from a patient in 2012 in Rhode Island, the United States [<xref ref-type="bibr" rid="CR9">9</xref>]. This patient had returned to the United States after a hospitalization in Vietnam [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par19">All isolates harboring <italic>bla</italic>
<sub>NDM-4</sub> tested had the same genetic structure surrounding <italic>bla</italic>
<sub>NDM-4</sub> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>), which was identical to that of NDM-1 producing <italic>K. pneumoniae</italic> strain KP4 plasmid pKP04NDM isolated in China (GenBank accession no. KU314941).</p><p id="Par20">OXA-48 producers had either one of two genetic structures surrounding <italic>bla</italic>
<sub>OXA-48</sub> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Of them, one was not reported (the second structure from the bottom in Fig. <xref rid="Fig1" ref-type="fig">1</xref>), whereas the other was identical with plasmids in OXA-48 producing <italic>K. pneumoniae</italic> strains 153,877&#8211;1 in Netherlands (GenBank accession no. KP659188), KP112 in France (GenBank accession no. LN864819), Kpn-E1.Nr7 in Switzerland (GenBank accession no. KM406491), E71T in Ireland (GenBank accession no. KC335143), KP1 and KP2 in France (GenBank accession no. KC757416 and KC757417, respectively), and 23 plasmid pIncL_M_DHQP1400954 in the USA (GenBank accession no CP016927).</p><p id="Par21">The <italic>bla</italic>
<sub>KPC-2</sub>, <italic>bla</italic>
<sub>NDM-1</sub>, <italic>bla</italic>
<sub>NDM-4</sub> and <italic>bla</italic>
<sub>OXA-48</sub> in each ST strain will be all located on plasmids and the sizes of the plasmids were shown in Table <xref rid="Tab1" ref-type="table">1</xref>.</p></sec><sec id="Sec12"><title>MLST and molecular phylogenetic analysis</title><p id="Par22">The clinical isolates of <italic>K. pneumoniae</italic> tested belonged to either one of ST15, ST16, ST147, ST307, ST395 and ST2353 (Table <xref rid="Tab1" ref-type="table">1</xref>). Of these isolates, 18 belonged to ST15 and 4 belonged to ST16 (Table <xref rid="Tab1" ref-type="table">1</xref>). The new sequence type, ST2353, belonged to CC147. Phylogenetic analysis revealed that the isolates belonging to ST15 formed the largest clade among the 27 isolates (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>). The 18 isolates belonging to ST15 harbored either one of two genes encoding carbapenemases, including <italic>bla</italic>
<sub>OXA-48</sub> and <italic>bla</italic>
<sub>NDM-4</sub>; and genes encoding aminoglycoside resistance factors, including <italic>aac(6&#8242;)-Ib-cr</italic> and <italic>rmtB</italic> (Table <xref rid="Tab1" ref-type="table">1</xref>). The phylogenetic tree among 18 ST15 isolates showed two subclades, A and B (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>). Of them, 16 belonging to subclade A harbored <italic>bla</italic>
<sub>OXA-48</sub> and 2 belonging to subclade B harbored <italic>bla</italic>
<sub>NDM-4</sub> (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>
<bold>a</bold> Molecular phylogeny of the 27&#160;<italic>K. pneumoniae</italic> strains<italic>.</italic> A maximum-likelihood phylogenetic tree was constructed from the 27 carbapenem-resistant isolates. The isolates belonging to ST15 formed the largest clade among the 27 isolates. <bold>b</bold> Molecular phylogeny of the 18&#160;<italic>K. pneumoniae</italic> strains belonging to ST15<italic>.</italic> A maximum-likelihood phylogenetic tree was constructed from the 18 carbapenem-resistant isolates. Of them, 16 belonging to subclade A harbored <italic>bla</italic>
<sub>OXA-48</sub> and 2 belonging to subclade B harbored <italic>bla</italic>
<sub>NDM-4</sub>
</p></caption><graphic xlink:href="12879_2017_2570_Fig2_HTML" id="MO2"/></fig>
</p></sec></sec><sec id="Sec13"><title>Discussion</title><p id="Par23">To our knowledge, this is the first report of the whole genome based molecular epidemiological analysis of carbapenem-resistant <italic>K. pneumoniae</italic> in Vietnam. Our study suggests that carbapenem-producing ST15 <italic>K. pneumoniae</italic> have been spreading in medical settings in Vietnam. A NDM-1 producing <italic>K. pneumoniae</italic> clinical isolate in Vietnam was firstly obtained from a urinary tract of a 62-year-old man in 2010 [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par24">This is the first report of NDM-4 or OXA-48 producing <italic>K. pneumoniae</italic> in Vietnam. NDM-4 was firstly detected in <italic>E. coli</italic> I5, which was recovered from a urine sample of a patient hospitalized in 2010 in India [<xref ref-type="bibr" rid="CR11">11</xref>]. Since then, NDM-4 producers were reported in <italic>Enterobacter cloacae</italic> in Sri Lanka [<xref ref-type="bibr" rid="CR12">12</xref>], <italic>E. coli</italic> in India [<xref ref-type="bibr" rid="CR13">13</xref>], Italy [<xref ref-type="bibr" rid="CR14">14</xref>] and Vietnam [<xref ref-type="bibr" rid="CR15">15</xref>], and <italic>K. pneumoniae</italic> in Japan [<xref ref-type="bibr" rid="CR16">16</xref>]. NDM-4 possessed increased hydrolytic activity toward carbapenems and several cephalosporins compared to NDM-1 [<xref ref-type="bibr" rid="CR11">11</xref>]. NDM-4 with an amino acid substitution at position 130 (Met to Leu) showed increased hydrolytic activity toward carbapenems and several cephalosporins compared to NDM-1 [<xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par25">ST15 will be an emerging high-risk multidrug-resistant clone with carbapenem-encoding genes, including <italic>bla</italic>
<sub>KPCs</sub>, <italic>bla</italic>
<sub>NDMs</sub> and <italic>bla</italic>
<sub>OXAs</sub>. Outbreaks caused by ST15 OXA-48 produces were reported in France and Spain [<xref ref-type="bibr" rid="CR2">2</xref>]. When Diancourt et al. [<xref ref-type="bibr" rid="CR17">17</xref>] developed a MLST for <italic>K. pneumoniae</italic> in 2005, they already detected ST15 isolates from several countries in Europe, such as Austria, France, Portugal and Poland, and the most of the isolates were resistant to ceftazidime and ciprofloxacin. ST15 <italic>K. pneumoniae</italic> isolates were reported to spread in medical settings in 2005 in Hungary [<xref ref-type="bibr" rid="CR2">2</xref>]. ST15 <italic>K. pneumoniae</italic> isolates were detected in other European countries, including Bulgaria, Croatia, Czech Republic, Denmark, Hungary, Italy, Netherlands, and Spain [<xref ref-type="bibr" rid="CR2">2</xref>]; they were also detected in Asian countries, including China, South Korea, Malaysia, Singapore, Thailand, and Vietnam [<xref ref-type="bibr" rid="CR2">2</xref>]; in African countries, including C&#244;te d&#8217;Ivoire, Madagascar, Morocco, and Senegal [<xref ref-type="bibr" rid="CR18">18</xref>]. These ST15 isolates frequently produced ESBL, including CTX-M, SHV-28 and TEM variants [<xref ref-type="bibr" rid="CR19">19</xref>], and moreover, they became to produce various carbapenemases, including KPCs, OXA-48, NDMs and VIM-4 [<xref ref-type="bibr" rid="CR19">19</xref>]. One of the well-recognized high-risk clones is CC258 which is frequently associated with KPCs-producing <italic>K. pneumoniae</italic> known as a high-risk clone [<xref ref-type="bibr" rid="CR19">19</xref>], and these isolates were reported many countries, such as the United States, Greek, Norway, Sweden, Italy, Poland, Canada, Brazil and Korea [<xref ref-type="bibr" rid="CR19">19</xref>]. ST11, a related clone ST258, was reported in KPCs-producing isolates mainly in China, but also in NDMs-producers from Czech Republic, Switzerland, Thailand, Australia, the United States, the United Arab Emirates and Greece [<xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par26">Etest seems a more reliable method to measure colistin MICs than broth microdilution method [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. In the present study, 11 isolates were resistant to colistin with MICs 4&#8211;32&#160;mg/L by broth microdilution method, although none of the isolates had colistin-resistant factors. Our previous study indicated that <italic>Enterobacteriacae</italic> isolates showed lower colistin MICs by Etest than by broth microdilution method [<xref ref-type="bibr" rid="CR20">20</xref>]. It is necessary to find feasible susceptibility testing methods of determining the MICs of polymyxins for clinical laboratories.</p></sec><sec id="Sec14"><title>Conclusions</title><p id="Par27">This study showed that carbapenem-resistant <italic>K. pneumoniae</italic> isolates belonged to international clones spread, and that these isolates harbored genes encoding various combinations of carbapenemases and 16S rRNA methylases, in a medical setting in Vietnam.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ESBLs</term><def><p id="Par4">extended-spectrum &#946;-lactamases</p></def></def-item><def-item><term>MBLs</term><def><p id="Par5">Metallo-&#946;-lactamases</p></def></def-item><def-item><term>MICs</term><def><p id="Par6">minimal inhibition concentration</p></def></def-item><def-item><term>MLST</term><def><p id="Par7">Multilocus sequence typing</p></def></def-item></def-list></glossary><ack><p>Biosafety Committee of the National Center for Global Health and Medicine (approval number: 27-M-52).</p><sec id="FPar1"><title>Funding</title><p id="Par29">This study was supported by Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), and a grant of the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development (AMED), a grant (27-A-1102) from International Health Cooperation Research, and JSPS KAKENHI Grant Number 16&#160;K19133.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par30">Nucleotide sequence accession numbers of the whole genome sequences of all 27 isolates have been deposited at GenBank as accession numbers DRA005275.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>TT and MT: Performed whole genome sequencing, analyzed data and drafted the manuscript. KS: Performed drug-susceptibility tests. TTTN: Performed clinical bacterial analyses. LTAT and TTP: Designed protocols and supervised this study at CRH. NO and TK: Designed protocols and supervised this study. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethical approval and consent to participate</title><p id="Par31">The study protocol was carefully reviewed and approved by the ethics committee of Cho Ray Hospital (approval number: 1644/QD-BVCR), the ethics committee of the National Center for Global Health and Medicine (No. 1268), respectively. Respectively. Individual informed consent was waived by the ethics committee listed above because this study used currently existing sample collected during the course of routine medical care and did not pose any additional risks to the patients.</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par32">Not applicable.</p></sec><sec id="FPar5"><title>Competing interests</title><p id="Par33">The authors declare that they have no competing interest.</p></sec><sec id="FPar6"><title>Publisher&#8217;s Note</title><p id="Par34">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordmann</surname><given-names>P</given-names></name><name><surname>Cuzon</surname><given-names>G</given-names></name><name><surname>Naas</surname><given-names>T</given-names></name></person-group><article-title>The real threat of <italic>Klebsiella pneumoniae</italic> carbapenemase-producing bacteria</article-title><source>Lancet Infect Dis</source><year>2009</year><volume>9</volume><issue>4</issue><fpage>228</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(09)70054-4</pub-id><?supplied-pmid 19324295?><pub-id pub-id-type="pmid">19324295</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CR</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name><name><surname>Kim</surname><given-names>YB</given-names></name><name><surname>Jeong</surname><given-names>BC</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name></person-group><article-title>Global dissemination of carbapenemase-producing <italic>Klebsiella pneumoniae</italic>: epidemiology, genetic context, treatment options, and detection methods</article-title><source>Front Microbiol</source><year>2016</year><volume>7</volume><fpage>895</fpage><?supplied-pmid 27379038?><pub-id pub-id-type="pmid">27379038</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yigit</surname><given-names>H</given-names></name><name><surname>Queenan</surname><given-names>AM</given-names></name><name><surname>Anderson</surname><given-names>GJ</given-names></name><name><surname>Domenech-Sanchez</surname><given-names>A</given-names></name><name><surname>Biddle</surname><given-names>JW</given-names></name><name><surname>Steward</surname><given-names>CD</given-names></name><etal/></person-group><article-title>Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of <italic>Klebsiella pneumoniae</italic></article-title><source>Antimicrob Agents Chemother</source><year>2001</year><volume>45</volume><issue>4</issue><fpage>1151</fpage><lpage>1161</lpage><pub-id pub-id-type="doi">10.1128/AAC.45.4.1151-1161.2001</pub-id><?supplied-pmid 11257029?><pub-id pub-id-type="pmid">11257029</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>D</given-names></name><name><surname>Toleman</surname><given-names>MA</given-names></name><name><surname>Giske</surname><given-names>CG</given-names></name><name><surname>Cho</surname><given-names>HS</given-names></name><name><surname>Sundman</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><etal/></person-group><article-title>Characterization of a new metallo-&#946;-lactamase gene, <italic>bla</italic><sub>NDM-1</sub>, and a novel erythromycin esterase gene carried on a unique genetic structure in <italic>Klebsiella pneumoniae</italic> sequence type 14 from India</article-title><source>Antimicrob Agents Chemother</source><year>2009</year><volume>53</volume><issue>12</issue><fpage>5046</fpage><lpage>5054</lpage><pub-id pub-id-type="doi">10.1128/AAC.00774-09</pub-id><?supplied-pmid 19770275?><pub-id pub-id-type="pmid">19770275</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornaglia</surname><given-names>G</given-names></name><name><surname>Giamarellou</surname><given-names>H</given-names></name><name><surname>Rossolini</surname><given-names>GM</given-names></name></person-group><article-title>Metallo-beta-lactamases: a last frontier for beta-lactams?</article-title><source>Lancet Infect Dis</source><year>2011</year><volume>11</volume><issue>5</issue><fpage>381</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(11)70056-1</pub-id><?supplied-pmid 21530894?><pub-id pub-id-type="pmid">21530894</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname><given-names>L</given-names></name><name><surname>Heritier</surname><given-names>C</given-names></name><name><surname>Tolun</surname><given-names>V</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name></person-group><article-title>Emergence of oxacillinase-mediated resistance to imipenem in <italic>Klebsiella pneumoniae</italic></article-title><source>Antimicrob Agents Chemother</source><year>2004</year><volume>48</volume><issue>1</issue><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1128/AAC.48.1.15-22.2004</pub-id><?supplied-pmid 14693513?><pub-id pub-id-type="pmid">14693513</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wachino</surname><given-names>J</given-names></name><name><surname>Yamane</surname><given-names>K</given-names></name><name><surname>Shibayama</surname><given-names>K</given-names></name><name><surname>Kurokawa</surname><given-names>H</given-names></name><name><surname>Shibata</surname><given-names>N</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name><etal/></person-group><article-title>Novel plasmid-mediated 16S rRNA methylase, RmtC, found in a <italic>Proteus mirabilis</italic> isolate demonstrating extraordinary high-level resistance against various aminoglycosides</article-title><source>Antimicrob Agents Chemother</source><year>2006</year><volume>50</volume><issue>1</issue><fpage>178</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1128/AAC.50.1.178-184.2006</pub-id><?supplied-pmid 16377684?><pub-id pub-id-type="pmid">16377684</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Tada T, Miyoshi-Akiyama T, Shimada K, Kirikae T. Biochemical analysis of the metallo-beta-lactamase NDM-3 from a multidrug-resistant <italic>Escherichia coli</italic> strain isolated in Japan. Antimicrob Agents Chemother. 2014 Mar;31</mixed-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>LB</given-names></name><name><surname>Tait-Kamradt</surname><given-names>A</given-names></name></person-group><article-title>A novel genetic region flanks the plasmid-carried <italic>bla</italic><sub>NDM-1</sub> isolated from a patient in Rhode Island in 2012</article-title><source>Antimicrob Agents Chemother</source><year>2013</year><volume>57</volume><issue>8</issue><fpage>4084</fpage><lpage>4085</lpage><pub-id pub-id-type="doi">10.1128/AAC.00937-13</pub-id><?supplied-pmid 23733455?><pub-id pub-id-type="pmid">23733455</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoang</surname><given-names>TH</given-names></name><name><surname>Wertheim</surname><given-names>H</given-names></name><name><surname>Minh</surname><given-names>NB</given-names></name><name><surname>Duong</surname><given-names>TN</given-names></name><name><surname>Anh</surname><given-names>DD</given-names></name><name><surname>Phuong</surname><given-names>TT</given-names></name><etal/></person-group><article-title>Carbapenem-resistant <italic>Escherichia coli</italic> and <italic>Klebsiella pneumoniae</italic> strains containing New Delhi metallo-&#946;-lactamase isolated from two patients in Vietnam</article-title><source>J Clin Microbiol</source><year>2013</year><volume>51</volume><issue>1</issue><fpage>373</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1128/JCM.02322-12</pub-id><?supplied-pmid 23100353?><pub-id pub-id-type="pmid">23100353</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordmann</surname><given-names>P</given-names></name><name><surname>Boulanger</surname><given-names>AE</given-names></name><name><surname>Poirel</surname><given-names>L</given-names></name></person-group><article-title>NDM-4 metallo-beta-lactamase with increased carbapenemase activity from <italic>Escherichia coli</italic></article-title><source>Antimicrob Agents Chemother</source><year>2012</year><volume>56</volume><issue>4</issue><fpage>2184</fpage><lpage>2186</lpage><pub-id pub-id-type="doi">10.1128/AAC.05961-11</pub-id><?supplied-pmid 22252797?><pub-id pub-id-type="pmid">22252797</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papagiannitsis</surname><given-names>CC</given-names></name><name><surname>Studentova</surname><given-names>V</given-names></name><name><surname>Chudackova</surname><given-names>E</given-names></name><name><surname>Bergerova</surname><given-names>T</given-names></name><name><surname>Hrabak</surname><given-names>J</given-names></name><name><surname>Radej</surname><given-names>J</given-names></name><etal/></person-group><article-title>Identification of a New Delhi metallo-&#946;-lactamase-4 (NDM-4)-producing <italic>Enterobacter cloacae</italic> from a Czech patient previously hospitalized in Sri Lanka</article-title><source>Folia Microbiol (Praha)</source><year>2013</year><volume>58</volume><issue>6</issue><fpage>547</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1007/s12223-013-0247-5</pub-id><pub-id pub-id-type="pmid">23546833</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>AU</given-names></name><name><surname>Parvez</surname><given-names>S</given-names></name></person-group><article-title>Detection of <italic>bla</italic><sub>NDM-4</sub> in <italic>Escherichia coli</italic> from hospital sewage</article-title><source>J Med Microbiol</source><year>2014</year><volume>63</volume><issue>Pt 10</issue><fpage>1404</fpage><lpage>1406</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.076026-0</pub-id><?supplied-pmid 25071158?><pub-id pub-id-type="pmid">25071158</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">Coppo E, Del Bono V, Ventura F, Camera M, Orengo G, Viscoli C, et al. Identification of a New Delhi metallo-&#946;-lactamase-4 (NDM-4)-producing <italic>Escherichia coli</italic> in Italy. BMC Microbiol. 2014 Jun 7;14:148,2180&#8211;14-148.</mixed-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakobsen</surname><given-names>L</given-names></name><name><surname>Hammerum</surname><given-names>AM</given-names></name><name><surname>Hansen</surname><given-names>F</given-names></name><name><surname>Fuglsang-Damgaard</surname><given-names>D</given-names></name></person-group><article-title>An ST405 NDM-4-producing <italic>Escherichia coli</italic> isolated from a Danish patient previously hospitalized in Vietnam</article-title><source>J Antimicrob Chemother</source><year>2014</year><volume>69</volume><issue>2</issue><fpage>559</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1093/jac/dkt356</pub-id><?supplied-pmid 24013194?><pub-id pub-id-type="pmid">24013194</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalifa</surname><given-names>HO</given-names></name><name><surname>Soliman</surname><given-names>AM</given-names></name><name><surname>Ahmed</surname><given-names>AM</given-names></name><name><surname>Shimamoto</surname><given-names>T</given-names></name><name><surname>Shimamoto</surname><given-names>T</given-names></name></person-group><article-title>NDM-4- and NDM-5-producing <italic>Klebsiella pneumoniae</italic> coinfection in a 6-month-old infant</article-title><source>Antimicrob Agents Chemother</source><year>2016</year><volume>60</volume><issue>7</issue><fpage>4416</fpage><lpage>4417</lpage><pub-id pub-id-type="doi">10.1128/AAC.00479-16</pub-id><?supplied-pmid 27185797?><pub-id pub-id-type="pmid">27185797</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diancourt</surname><given-names>L</given-names></name><name><surname>Passet</surname><given-names>V</given-names></name><name><surname>Verhoef</surname><given-names>J</given-names></name><name><surname>Grimont</surname><given-names>PA</given-names></name><name><surname>Brisse</surname><given-names>S</given-names></name></person-group><article-title>Multilocus sequence typing of <italic>Klebsiella pneumoniae</italic> nosocomial isolates</article-title><source>J Clin Microbiol</source><year>2005</year><volume>43</volume><issue>8</issue><fpage>4178</fpage><lpage>4182</lpage><pub-id pub-id-type="doi">10.1128/JCM.43.8.4178-4182.2005</pub-id><?supplied-pmid 16081970?><pub-id pub-id-type="pmid">16081970</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breurec</surname><given-names>S</given-names></name><name><surname>Guessennd</surname><given-names>N</given-names></name><name><surname>Timinouni</surname><given-names>M</given-names></name><name><surname>Le</surname><given-names>TA</given-names></name><name><surname>Cao</surname><given-names>V</given-names></name><name><surname>Ngandjio</surname><given-names>A</given-names></name><etal/></person-group><article-title><italic>Klebsiella pneumoniae</italic> Resistant to third-generation cephalosporins in five African and two Vietnamese major towns: Multiclonal population structure with two major international clonal groups, CG15 and CG258</article-title><source>Clin Microbiol Infect</source><year>2013</year><volume>19</volume><issue>4</issue><fpage>349</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2012.03805.x</pub-id><?supplied-pmid 22390772?><pub-id pub-id-type="pmid">22390772</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitout</surname><given-names>JD</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name><name><surname>Poirel</surname><given-names>L</given-names></name></person-group><article-title>Carbapenemase-producing <italic>Klebsiella pneumoniae</italic>, a key pathogen set for global nosocomial dominance</article-title><source>Antimicrob Agents Chemother</source><year>2015</year><volume>59</volume><issue>10</issue><fpage>5873</fpage><lpage>5884</lpage><pub-id pub-id-type="doi">10.1128/AAC.01019-15</pub-id><?supplied-pmid 26169401?><pub-id pub-id-type="pmid">26169401</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nhung</surname><given-names>PH</given-names></name><name><surname>Miyoshi-Akiyama</surname><given-names>T</given-names></name><name><surname>Phuong</surname><given-names>DM</given-names></name><name><surname>Shimada</surname><given-names>K</given-names></name><name><surname>Anh</surname><given-names>NQ</given-names></name><name><surname>Binh</surname><given-names>NG</given-names></name></person-group><article-title>Thanh do V, Ohmagari N, Kirikae T: evaluation of the Etest method for detecting colistin susceptibility of multidrug-resistant gram-negative isolates in Vietnam</article-title><source>J Infect Chemother</source><year>2015</year><volume>21</volume><issue>8</issue><fpage>617</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/j.jiac.2015.04.002</pub-id><?supplied-pmid 25960156?><pub-id pub-id-type="pmid">25960156</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>LJ</given-names></name><name><surname>Salim</surname><given-names>M</given-names></name><name><surname>Cober</surname><given-names>E</given-names></name><name><surname>Richter</surname><given-names>SS</given-names></name><name><surname>Perez</surname><given-names>F</given-names></name><name><surname>Salata</surname><given-names>RA</given-names></name><name><surname>Kalayjian</surname><given-names>RC</given-names></name><name><surname>Watkins</surname><given-names>RR</given-names></name><name><surname>Marshall</surname><given-names>S</given-names></name><name><surname>Rudin</surname><given-names>SD</given-names></name><name><surname>Domitrovic</surname><given-names>TN</given-names></name><name><surname>Hujer</surname><given-names>AM</given-names></name><name><surname>Hujer</surname><given-names>KM</given-names></name><name><surname>Doi</surname><given-names>Y</given-names></name><name><surname>Kaye</surname><given-names>KS</given-names></name><name><surname>Evans</surname><given-names>S</given-names></name><name><surname>Fowler</surname><given-names>VG</given-names><suffix>Jr</suffix></name><name><surname>Bonomo</surname><given-names>RA</given-names></name><name><surname>van Duin</surname><given-names>D</given-names></name></person-group><article-title>Antibacterial resistance leadership group: Colistin resistance in Carbapenem-resistant <italic>Klebsiella pneumoniae</italic>: laboratory detection and impact on mortality</article-title><source>Clin Infect Dis</source><year>2017</year><volume>64</volume><issue>6</issue><fpage>711</fpage><lpage>718</lpage><?supplied-pmid 27940944?><pub-id pub-id-type="pmid">27940944</pub-id></element-citation></ref></ref-list></back></article>